Latest filingSep 03, 2026Most recent Form 4
TXG
10x Genomics, Inc.
NasdaqIndustrialsLaboratory Analytical Instruments
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$369M7 sells
Net open-market-$369M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period9transactions
- S · Open-market sells · dominant7 · 78%
- G · Gifts2 · 22%
Activity by reported role
A joint filing can contribute to multiple roles9transactions
- Director · dominant4 · 44%
- Chief executive officer3 · 33%
- Chief financial officer1 · 11%
- SR1 · 11%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (5)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSaxonov SergeClass A Common Stock · Direct
1,075,249Sep 01, 2026
Teichmann Sarah A.Class A Common Stock · Direct
28,058Aug 14, 2026
Suliman ShehnaazClass A Common Stock · Direct
31,161Aug 24, 2026
Hindson Benjamin J.Class A Common Stock · Direct
488,182Aug 24, 2026
Taich AdamClass A Common Stock · Direct
362,732Aug 24, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TXG transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
10x Genomics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at 10x Genomics, Inc.?
Saxonov Serge, Taich Adam, Hindson Benjamin J., SULIMAN SHEHNAAZ, Teichmann Sarah A..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Saxonov Serge reported a sale on Aug 24, 2026 valued at $116M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $3,694,243.93. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.